Short-term effects of Finnish sauna bathing on blood-based markers of cardiovascular function in non-naive sauna users by Kunutsor, Setor K. et al.
                          Kunutsor, S. K., Häkkinen, A., Zaccardi, F., Laukkanen, T., Lee, E., Willeit,
P., ... Laukkanen, J. A. (2018). Short-term effects of Finnish sauna bathing
on blood-based markers of cardiovascular function in non-naive sauna users.
Heart and Vessels. https://doi.org/10.1007/s00380-018-1202-9
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1007/s00380-018-1202-9
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Springer at
https://link.springer.com/article/10.1007%2Fs00380-018-1202-9 . Please refer to any applicable terms of use of
the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
Vol.:(0123456789) 
Heart and Vessels 
https://doi.org/10.1007/s00380-018-1202-9
ORIGINAL ARTICLE
Short‑term effects of Finnish sauna bathing on blood‑based markers 
of cardiovascular function in non‑naive sauna users
Setor K. Kunutsor1,2 · Arja Häkkinen3 · Francesco Zaccardi4 · Tanjaniina Laukkanen5 · Earric Lee3 · Peter Willeit6,7 · 
Hassan Khan8 · Jari A. Laukkanen3,5,9 
Received: 29 January 2018 / Accepted: 15 June 2018 
© The Author(s) 2018
Abstract
Emerging evidence suggests that sauna bathing is associated with reduced risk of cardiovascular and all-cause mortality 
events. However, the biochemical pathways by which sauna bathing might confer its effects on cardiovascular function are 
not certain. We aimed to study the acute effects of Finnish sauna bathing on various blood-based cardiovascular biomarkers. 
The study included 102 non-naive sauna users (54% male) with mean age of 51.9 years, who had at least one cardiovascular 
risk factor. Participants underwent a 30-min single sauna session (mean temperature, 73 °C). Biochemical profiling was 
conducted before, immediately after sauna and 30-min post-sauna. Overall median N-terminal pro-B-type natriuretic peptide 
(NT-proBNP) level (n = 20 participants) was 46.0 ng/L before sauna exposure, which increased to 50.5 ng/l immediately after 
sauna (median change, + 12.00%; p < 0.001) and remained persistent at 30-min post-sauna (median change from pre-sauna 
to post-30-min sauna, + 13.93%; p < 0.001). The changes were more evident in males compared with females. There were 
no significant changes in overall levels of high sensitivity C-reactive protein, creatine kinase, high sensitivity troponin I, 
and creatine kinase-MBm. However, levels of creatine kinase increased in males (median change immediately after sauna, 
+ 2.99%; p = 0.024). Levels of NT-proBNP increased after sauna exposure. The increase in levels of creatine kinase was more 
evident in males. Long-term interventional studies are warranted to evaluate if these biomarkers are involved in pathways 
underlying the associations of sauna bathing with cardiovascular outcomes.
Keywords Sauna bathing · Experimental study · Cardiovascular disease · Biomarkers
Introduction
Repeated passive heat therapy has been shown to have ben-
eficial effects on the cardiovascular system by improving 
endothelial function, arterial stiffness, and microvascular 
function; reducing carotid intima media thickness, blood 
pressure, markers of oxidative stress, and brain natriu-
retic peptides; as well as increasing parasympathetic and 
decreasing sympathetic nervous activity [1–5]. Sauna bath-
ing, a form of passive heat therapy, is an activity which is a 
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tradition in Finland and commonly used for relaxation and 
pleasure and is becoming increasingly popular in many other 
cultures [6, 7]. Finnish sauna bathing has been linked to 
improved cardiovascular function as well as several health 
benefits. Emerging evidence suggests that regular sauna 
bathing is associated with lower blood pressure [8], reduced 
risk of cardiovascular disease (CVD) mortality [9], stroke 
[10], dementia [11], and pulmonary diseases [12, 13], as 
well as reduced all-cause mortality risk [9]. The specific car-
diovascular adaptations produced by long-term sauna bath-
ing is not certain, but the effects of sauna bathing on cardio-
metabolic health outcomes have been linked to its beneficial 
impact on circulatory and cardiovascular function. Regular 
long-term sauna bathing has been shown to produce blood 
pressure lowering effects [14] as well as reducing levels of 
markers of inflammation [15, 16].
Evidence on the beneficial effects of sauna bathing on cir-
culatory and cardiovascular function has mostly been based 
on studies evaluating the short-term effects of sauna. Short-
term or acute sauna exposure has been shown to produce 
blood pressure lowering effects [17], decrease peripheral 
vascular resistance [17, 18] and arterial stiffness [8, 19] as 
well as improve arterial compliance [19]. Short-term sauna 
exposure also activates the sympathetic nervous system and 
the renin–angiotensin–aldosterone system, and the hypo-
thalamus–pituitary–adrenal hormonal axis with short-term 
increases in levels of their associated hormones [20]. Other 
potential pathways by which sauna therapy may exert its car-
dioprotective effects are via positive modulation in levels of 
blood-based established cardiovascular risk factors such as 
lipids, glucose, markers of insulin resistance, natriuretic pep-
tides, and cardiac troponins. There is, however, limited evi-
dence on the effects of short-term sauna exposure on these 
circulating biomarkers. Several studies on the short-term 
effects of other passive heat therapies such as Waon ther-
apy, infrared saunas, intermittent warm water immersion, 
and whole-body hyperthermia have, however, been shown 
to have beneficial effects on parameters of cardiovascular 
function such as (1) reductions in concentrations of circulat-
ing arterial endothelial- and platelet-derived microparticles 
[21] and markers of inflammation and oxidative stress [3, 
22–25]; (2) protection against impaired vascular function 
[26]; (3) induction in systemic and hemodynamic responses 
(blood pressure lowering and shear rate increases) [27, 28] 
and improved vascular function [29]; and (4) reduction in 
arterial stiffness [30].
Given the overall evidence which suggests that short-term 
heat therapy may produce widespread beneficial effects on 
vascular function, our hypothesis was that a short-term 
exposure to Finnish sauna will produce beneficial changes 
in levels of circulating cardiovascular biomarkers. In this 
context, we conducted this exploratory experimental non-
controlled study to show the effects of 30 min of Finnish 
sauna bathing on several parameters of cardiovascular func-
tion. We have previously reported on the potential beneficial 
effects of acute sauna exposure on arterial stiffness and com-
pliance, blood pressure, haematological variables, as well as 
renal markers [8, 19]. In this report, we study the effects of 
30 min of Finnish sauna bathing on circulating blood-based 
markers of cardiovascular function [such as high sensitivity 
C-reactive protein (hsCRP), creatine kinase, hs-troponin I, 
creatine kinase-MBm, and N-terminal pro-B-type natriuretic 
peptide (NT-proBNP)], immediately after sauna and 30-min 
post-sauna.
Materials and methods
Participants
We recruited 110 participants without pre-existing CVD 
from the city of Jyväskylä, Central Finland region, through 
the local out-of-hospital community health care center. 
Study participants were asymptomatic with at least one car-
diovascular risk factor, such as a history of smoking, dyslipi-
daemia, hypertension, obesity, diabetes, or family history of 
coronary heart disease (CHD). Participants (n = 8) with any 
form of acute or pre-existing CVD were excluded from the 
study. A total of 102 participants were finally included in the 
study. Given the challenge in recruiting naive or non-sauna 
users to sauna studies in Finland, because the majority of the 
population use sauna regularly, our study sample were all 
sauna users. Prior to study entry, participants were provided 
with information about the research purposes and measure-
ment procedures and were screened by a cardiac specialist. 
The study design and protocol were approved by the institu-
tional review board of the Central Finland Hospital District 
ethical committee, Jyväskylä, Finland (Dnro 5U/2016). All 
study participants provided written informed consent.
Baseline assessments and clinical examination
Baseline data collection, as well as a clinical evaluation, was 
conducted on separate days prior to the experiment. Baseline 
assessments and sauna measurements were conducted dur-
ing June and November 2016. Assessment of demograph-
ics, lifestyle factors (e.g., smoking, physical activity, and 
sauna bathing habits), prevalent diseases, and regular use of 
medication were based on a detailed self-reported question-
naire which was checked by a cardiologist during screen-
ing. Physical activity and sauna bathing habits over the past 
1 year were assessed. The duration and frequency of physical 
activity were also explored. Information collected on regu-
lar sauna bathing habits was based on frequency (weekly 
sauna sessions), duration, and temperature (measured using 
a thermometer located in the sauna room). Medical history, 
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physical examination, and resting electrocardiogram (ECG) 
were assessed during the screening visit. Resting blood 
pressure was estimated as the mean of two measurements 
obtained, while the participant was in the supine position, 
based on a standardized measurement protocol. Body mass 
index (BMI) was calculated by dividing weight in kilograms 
by the square of height in meters.
Finnish sauna exposure
The traditional Finnish sauna with dry air and relatively 
high temperature was used as our exposure [9]. It consisted 
of a typical Finnish sauna bathing session which lasted for 
30 min. However, there was a short, 2-min shower after the 
first 15 min [8]. Sauna bathing sessions took place between 
9.00 and 11.00 h on the specified study days. Sauna rooms 
were gender specific and all participants wore their own 
swim suits during the sauna sessions. Only one participant 
was allowed in the sauna bath at a time. Sauna temperature 
was set at 80 °C and this was controlled and monitored by 
internal temperature sensors designed by Harvia Oy, Fin-
land. Temperature assessment was continuous with the use 
of a two-channel thermometer in the sauna room and the 
data were collected during experiment. The temperature sen-
sor also monitored the humidity of the sauna room. Based 
on overall data collected, the mean ± standard deviation 
(SD) temperature was 73 ± 2 °C with a relative humidity of 
10–20%. Study participants were monitored and supervised 
by a physician and were allowed to leave the sauna at any 
time they felt any discomfort. All participants underwent the 
recommended sauna protocol without any problems. Partici-
pants were given 500 mL of still water at room temperature 
to drink during the entire sauna session, and including the 
recovery period post-sauna. The recovery period was for 
30 min which involved resting in a designated relaxing wait-
ing lounge (mean temperature 21 °C). Body temperature was 
measured for each participant from the ear.
Assessment of laboratory markers
Non-fasting blood samples were taken about 2 h prior to 
sauna sessions. Participants were instructed to abstain from 
strenuous physical activity 24 h before the blood samples 
were taken. Venous blood samples were collected by a quali-
fied laboratory technician from the antecubital vein in the 
sitting position, using sterile needles, and were collected into 
serum and plasma tubes (BD Vacutainer, Plymouth. UK). 
Whole blood samples were stored for 10 min before being 
centrifuged at 3500 rpm (Megafuge, Heraeus, Germany) and 
serum and plasma samples stored at − 80 °C until analysis. 
Serum total cholesterol, high-density lipoprotein (HDL), 
low-density lipoprotein (LDL), Apolipoprotein A1 (ApoA1), 
Apolipoprotein B (Apo B), triglycerides, and plasma glucose 
concentrations were measured using a spectrophotometry 
analyzer (Konelab 20XTi, Thermo Fisher Scientific, Van-
taa, Finland). Venous blood samples for the determination 
of plasma inflammatory markers and cardiac biomarkers 
were analyzed using chemiluminecent immunoassay by Sie-
mens Immulite 2000 XPi (Siemens Healthcare Diagnostics 
Products Ltd., Llanberies, UK) analyzer. Measurements of 
NT-proBNP were conducted in only a random sample of 
participants because of the high costs associated with these 
assays. Creatine kinase was measured in heparinised plasma 
by Konelab 20XTi, (Thermo Fisher Scientific, Vantaa, Fin-
land). All biomarkers were assessed before and after sauna.
Statistics
All the cardiovascular biomarkers (hsCRP, creatine kinase, 
hs-troponin I, creatine kinase-MBm, and NT-proBNP) eval-
uated were skewed and thus were log transformed to approx-
imate normal distributions. Data are presented as means 
(SD) or median (interquartile range, IQR) for continuous 
variables according to their distribution and as proportions 
for categorical variables. Normality was checked using the 
Shapiro–Wilk test as well as through observing the Q–Q 
plots. Repeated measure analysis of variance (ANOVA) 
was used to estimate within-group differences and changes 
by time. Paired t tests were used to compare within-group 
changes in biomarkers assessed immediately after sauna and 
30-min post-sauna. Given the skewness of cardiovascular 
biomarkers, median percent changes were calculated as they 
are robust and provide strong reductions in estimation bias 
and variance in the presence of outliers [31]. A two-sided 
significance level was set at p ≤ 0.05. All statistical analyses 
were carried out with Stata version 14.1 (Stata Corp, College 
Station, Texas, USA).
Results
Characteristics of population
Baseline characteristics of the 102 study participants are 
shown in Table 1. The majority of participants were male 
(n = 56). The mean (SD) of age, BMI, and SBP were 51.9 
(SD 9.2) years, 27.9 (4.7) kg/m2, and 136 (16) mmHg, 
respectively. Current smokers made up 14.4% of the 
study population. Lipid parameters were generally similar 
between males and females. Male participants had higher 
levels of creatine kinase, creatine kinase-MBm, and NT-
proBNP compared with females. Levels of hsCRP and hs-
troponin I were higher in female. Levels of these cardio-
vascular risk markers in study participants were generally 
within the normal reference ranges. Mean plasma creati-
nine level was 114.5 U/L in this population. Dyslipidaemia 
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Table 1  Baseline characteristics
N (M/F) Total M F
Clinical characteristics
 Age (years) 56/46 51.9 ± 9.2 51.8 ± 10.1 52.0 ± 8.3
 Body weight (kg) 56/46 82.7 ± 16.0 88.9 ± 13.4 75.5 ± 15.9
 Body mass index (kg/m2) 56/46 27.2 (24.5–30.7) 27.7 (25.1–30.6) 26.7 (23.8–31.0)
 Smokers 56/46 14 (14.4%) 9 (17.7%) 5 (10.9%)
 Systolic blood pressure (mmHg) 56/46 136.5 ± 16.2 137.2 ± 14.4 135.8 ± 18.3
 Diastolic blood pressure (mmHg) 56/46 82.1 ± 9.6 84.2 ± 9.6 79.6 ± 9.2
 Resting HR (bpm) 56/46 64 (59–70) 64 (56.5–70) 65 (61–70)
 Total cholesterol  (Choltot; mmol/L) 56/46 5.4 ± 1.0 5.4 ± 1.1 5.4 ± 0.9
 Low-density lipoprotein (LDL; mmol/L) 56/46 3.0 ± 0.8 3.1 ± 0.8 3.0 ± 0.8
 High-density lipoprotein (HDL; mmol/L) 56/46 1.4 ± 0.4 1.3 ± 0.4 1.5 ± 0.4
 Triglycerides (mmol/L) 56/46 1.6 (1.0–2.3) 1.8 (1.2–2.6) 1.3 (0.9–2.0)
 Glucose (mmol/L) 56/46 5.2 ± 0.9 5.3 ± 1.0 5 ± 0.9
 Apo A1 (g/L) 56/46 1.5 (1.3–1.7) 1.5 (1.3–1.7) 1.6 (1.4–1.8)
 Apo B (g/L) 56/46 1.0 (0.8–1.2) 1.0 (0.8–1.2) 0.9 (0.7–1.1)
Cardiovascular risk markers
 High sensitivity C-reactive protein (mg/L) (mg/L) 54/46 1.26 (0.52–2.79) 1.12 (0.59–3.31) 1.39 (0.48–2.51)
 Creatine kinase (U/L) 54/46 114.5 (81.0–160.0) 132.5 (100.0–189.0) 99.5 (71.0–122.0)
 High sensitivity troponin I (ng/mL) 54/46 0.003 (0.001–0.015) 0.002 (0.001–0.014) 0.005 (0.001–0.015)
 Creatine kinase-MBm (ng/mL) 54/46 1.39 ( 0.99–2.14) 1.90 (1.34–2.67) 1.18 (0.71–1.42)
 N-terminal pro-B-type natriuretic peptide (ng/L) 8/12 46.0 (32.5–58.0) 48.0 (25.5–53.5) 44.0 (34.5–74.5)
Self-reported conditions and family history
 Hypertension 56/46 14 (14.3%) 11 (21.2%) 3 (6.5%)
 Hypercholesterolaemiaa 56/44 63 (63.0%) 37 (66.1%) 26 (59.1%)
 Type 1 diabetes 56/46 2 (2.0%) 1 (1.9%) 1 (2.2%)
 Type 2 diabetes 56/46 1 (1.0%) 1 (1.9%) 0 (0.0%)
 Respiratory (incl. Asthma) 56/46 5 (5.1%) 2 (3.8%) 3 (6.5%)
 Thyroid disease (hypo) 56/46 3 (3.1%) 1 (1.9%) 2 (4.3%)
 Skin disease (atopic) 56/46 4 (4.1%) 3 (5.8%) 1 (2.2%)
 Rheumatoid arthritis 56/46 1 (1.0%) 0 (0.0%) 1 (2.2%)
 Family history of coronary heart disease 56/46 33 (34.0%) 15 (29.4%) 18 (39.1%)
Self-reported sauna habits and physical activity
 Frequency of sauna, times/week 56/46
  1 16 (16.3%) 6 (11.5%) 10 (21.7%)
  2 16 (16.3%) 7 (13.5%) 9 (19.6%)
  3 43 (43.9%) 23 (44.2%) 20 (43.5%)
  4 23 (23.5%) 16 (30.8%) 7 (15.2%)
 Duration of sauna, minutes/session 56/45
  < 20 17 (17.5%) 8 (15.4%) 9 (20.0%)
  20–40 55 (56.7%) 28 (53.8%) 27 (60.0%)
  41–60 21 (21.6%) 14 (26.9%) 7 (15.6%)
  > 60 4 (4.1%) 2 (3.8%) 2 (4.4%)
 Average temperature of sauna, °C 56/46 72.0 ± 8.5 73.0 ± 9.0 70.9 ± 7.8
 Frequency of physical activity, times/week 56/46
  0 1 (1.6%) 1 (3.3%) 0 (0.0%)
  1 16 (25.8%) 7 (23.3%) 9 (28.1%)
  2–3 20 (32.3%) 11 (36.7%) 9 (28.1%)
  4–5 19 (30.6%) 9 (30.0%) 10 (31.3%)
  > 5 6 (9.7%) 2 (6.7%) 4 (12.5%)
 Duration of physical activity, minutes/session 56/46
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(63.0%) and family history of CHD (34.0%) were the most 
common cardiovascular risk factors in the study popula-
tion, followed by hypertension at 14.3%. Forty-four per-
cent of subjects had both dyslipidaemia and a family his-
tory of CHD. A few participants had underlying clinical 
conditions such as type 1 diabetes (2.0%), type 2 diabetes 
(1.0%), respiratory diseases (5.1%), thyroid disease (3.1%), 
skin disease (4.0%), and rheumatoid arthritis (1.0%). Base-
line assessment of sauna bathing showed that the majority 
of participants used sauna baths 3 times per week (43.9%). 
Commonly, a sauna session lasted between 20 and 40 min 
for most participants (56.7%) and the average self-reported 
temperature was 72 °C. Most participants reported > 1–3 
sessions of physical activity per week (32.3%) followed 
by > 3–5 sessions per week (30.6%). The majority of par-
ticipants (37.1%) spent > 60 min during a typical physical 
activity session.
Sauna and changes in cardiovascular biomarkers
Table 2 and Fig. 1 show levels of evaluated cardiovas-
cular biomarkers at pre-sauna, immediately after sauna, 
and 30  min after sauna. Overall NT-proBNP levels 
were 46.0 ng/L before sauna exposure, which increased 
to 50.5 ng/L immediately after sauna (median percent-
age change, 12.00%; p < 0.001). Increased levels of 
NT-proBNP remained persistent at 30-min post-sauna, 
51.5 ng/L (median percentage change from pre-sauna to 
post-30-min sauna, 13.93%; p < 0.001) (Table 3). These 
changes were more evident in males compared with 
females. Overall, there were no statistically significant 
changes in levels of hsCRP, creatine kinase, hs-troponin 
I, and creatine kinase-MBm immediately after sauna and 
30 min after sauna. However, levels of creatine kinase 
increased immediately after sauna in males; from 132.5 to 
149.5 U/L (median relative change, 2.99%; p = 0.024). 
Levels of hs-troponin I seemed to increase immediately 
after sauna in males, but this change was very small and 
marginally significant (0.002–0.005 ng/mL; p = 0.058) 
(Table 3).  
Discussion
In this first experimental study to assess the acute effects 
of Finnish sauna exposure on specific blood-based cardio-
vascular biomarkers, we have shown that levels of cardiac 
markers such as NT-proBNP and creatine kinase increase 
immediately after 30 min of exposure to sauna. The increase 
in levels was more pronounced for NT-proBNP and these 
elevated levels seem to be sustained 30 min after the sauna 
exposure. The changes in biomarkers such as creatine kinase 
were generally more evident in males. There were no statis-
tically significant changes in levels of hsCRP and creatine 
kinase-MBm both immediately after sauna and post-30-min 
sauna; though there was a suggestion of an increase in levels 
of hs-troponin I immediately after sauna in males, but this 
change was very negligible and marginally significant.
Emerging data suggest that long term or repeated expo-
sure to sauna bathing is associated with reduced risk of car-
diovascular outcomes such as hypertension [14, 32], stroke, 
cardiovascular, and overall mortality [9]. Studies of both 
Finnish sauna bathing and other passive heat therapies sug-
gest that the protective effects of thermal therapy on these 
outcomes might be mediated via their beneficial effects on 
blood pressure, endothelial function, microvascular func-
tion, arterial stiffness, vascular resistance, and carotid intima 
media thickness [1–5, 8, 17–19]. Since levels of blood-based 
cardiovascular markers such as CRP, creatine kinase, tro-
ponin, NT-proBNP, markers of inflammation and oxidative 
stress, and lipids have been linked to cardiovascular out-
comes such as CHD, stroke, and heart failure [33–36], it is 
biologically plausible that the effects of sauna bathing on 
cardiovascular function might be mediated through benefi-
cial changes in these cardiac-related biomarkers. Indeed, in 
two studies that evaluated the effect of Finnish sauna bathing 
on lipid profile, there were significant decreases in total cho-
lesterol and LDL cholesterol after 2–3 weeks of sauna expo-
sure [37, 38]. One study suggested that the lipid changes as 
a result of sauna exposure were similar to that produced by 
moderate-intensity physical exercise [37]. We have also pre-
viously shown that long-term sauna exposure is associated 
with reduction in levels of markers of inflammation [15, 16]. 
Values are reported as mean ± SD or median (interquartile range) for continuous variables and n (%) for categorical variables
M male, F female
a Total Cholesterol > 5.17 mmol/L
Table 1  (continued)
N (M/F) Total M F
  <20 7 (10.0%) 2 (5.7%) 5 (14.3%)
  20–40 18 (25.7%) 12 (34.3%) 6 (17.1%)
  41–60 19 (27.1%) 11 (31.4%) 8 (22.9%)
  > 60 26 (37.1%) 10 (28.6%) 16 (45.7%)
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Table 2  Levels of 
cardiovascular biomarkers 
before and after sauna
CRP C-reactive protein, NT-proBNP N-terminal pro-B-type natriuretic peptide
*p value for anova; all values are reported as median (interquartile range)
N (M/W) Total M F
High sensitivity CRP (mg/L)
 Pre 54/46 1.26 (0.52–2.79) 1.12 (0.59–3.31) 1.39 (0.48–2.51)
 Post 53/46 1.22 (0.51–3.08) 1.09 (0.57–3.21) 1.48 (0.45–2.86)
 Post 30 min 51/38 1.17 (0.53–2.57) 1.17 (0.59–2.94) 1.28 (0.40–2.42)
p value* 0.852 0.768 0.535
Creatine kinase (U/L)
 Pre 54/46 114.5 (81.0–160.0) 132.5 (100.0–189.0) 99.5 (71.0–122.0)
 Post 54/46 121.0 (88.0–166.0) 149.5 (107.0–193.0) 98.0 (69.0–130.0)
 Post 30 min 50/38 115.5 (84.5–165.5) 137.0 (104.0–195.0) 101.0 (74.0–125.0)
p value* 0.037 0.027 0.059
High sensitivity troponin I (ng/mL)
 Pre 54/46 0.003 (0.001–0.015) 0.002 (0.001–0.014) 0.005 (0.001–0.015)
 Post 53/46 0.005 (0.001–0.016) 0.005 (0.001–0.022) 0.003 (0.001–0.013)
 Post 30 min 50/38 0.002 (0.001–0.018) 0.002 (0.001–0.015) 0.001 (0.001–0.018)
p value* 0.331 0.145 0.736
Creatine kinase-MBm (ng/mL)
 Pre 54/46 1.39 (0.99–2.14) 1.90 (1.34–2.67) 1.18 (0.71–1.42)
 Post 53/46 1.45 (0.97–2.15) 1.93 (1.31–2.38) 1.17 (0.64–1.60)
 Post 30 min 51/38 1.50 (1.09–2.10) 1.91 (1.36–2.43) 1.17 (0.82–1.45)
p value* 0.296 0.450 0.562
NT-proBNP (ng/L)
 Pre 8/12 46.0 (32.5–58.0) 48.0 (25.5–53.5) 44.0 (34.5–74.5)
 Post 8/12 50.5 (37.0–66.5) 56.0 (31.0–59.0) 46.5 (39.5–86.5)
 Post 30 min 8/12 51.5 (37.0–70.0) 55.0 (31.5–69.5) 48.5 (37.0–78.0)
p value* <0.0001 <0.0001 0.066
Fig. 1  Levels of cardiovascular biomarkers at pre-sauna, immediately after sauna, and 30 min after sauna. Data are reported as medians (inter-
quartile ranges)
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However, some of the mechanistic pathways implicated for 
the cardioprotective effects of sauna bathing did not appear 
to be consistent with our current findings, as we observed 
only minor changes due to a single sauna session. It is dif-
ficult to compare our results in the context of the previous 
studies, as this is the first study to evaluate the acute effects 
of a traditional Finnish sauna exposure on circulating levels 
of these particular cardiovascular risk markers. However, a 
previously published study demonstrated a delayed increase 
in plasma levels of atrial natriuretic peptide (ANP) after 
20 min of exposure in a Finnish sauna [39].
A number of studies evaluating the effects of other pas-
sive heat therapies such as Waon therapy, infrared saunas, 
intermittent warm water immersion, and whole-body hyper-
thermia have demonstrated beneficial modulation in levels 
of blood-based circulating markers of cardiovascular func-
tion. While studies on the acute effects of these therapies 
are sparse, there are a number of studies on the repeated or 
long-term effects of these thermal therapies. In individuals 
exposed to about 56 min of passive heat stress, circulating 
concentrations of arterial endothelial- and platelet-derived 
microparticles (which may play a pathogenic role in vascular 
disease [40–42]) were found to be markedly reduced [21]. 
Repeated passive heat therapy has also been shown to reduce 
levels of circulating markers of inflammation and oxidative 
stress [3, 22–25]. Ohori et al. demonstrated that 3 weeks of 
repeated thermal treatment (Waon therapy) in patients with 
chronic heart failure was associated with improvement in 
levels of BNPs and plasma norepinephrine [43]. In several 
other studies in which patients with heart failure were treated 
with infrared-ray sauna therapy for several weeks, decreases 
in concentrations of BNPs were demonstrated [44, 45]. 
An essential finding in our study was the elevation in NT-
proBNP levels after sauna bathing, which may be an indica-
tor of increased workload of the cardiovascular system and 
heart muscle due to a single 30-min sauna exposure. There 
is no active function of skeletal muscles during the sauna 
bathing, which is in contrast to the training response experi-
enced during physical activity. However, increased heart rate 
increases myocardial workload and oxygen demand similar 
to physical exercise. Supporting our preliminary findings, 
in a previous exercise-exposure study, a significant increase 
Table 3  Median percentage 
changes in cardiovascular 
biomarkers
Values are reported as median (95% confidence intervals); p values are from paired T tests based on the log 
transformed variables
CRP C-reactive protein, NT-proBNP N-terminal pro-B-type natriuretic peptide
Total M F
High sensitivity CRP (mg/L)
 Post 1.71 (− 0.38, 5.28) 5.13 (1.03, 9.49) − 0.80 (− 3.98, 2.79)
 Post 30 min 0.62 (− 1.40, 2.58) 3.06 (− 1.09, 5.45) − 0.89 (− 2.06, 1.79)
p value (post versus pre) 0.635 0.607 0.927
p value (post 30 versus pre) 0.532 0.345 0.239
Creatine kinase (U/L)
 Post 1.82 (− 0.96, 3.34) 2.99 (1.66, 4.76) − 1.61 (− 3.02, 2.78)
 Post 30 min − 0.90 (− 2.70, 1.47) 0.00 (− 1.38, 2.40) − 2.70 (− 5.10, 1.68)
 p value (post versus pre) 0.085 0.024 0.511
 p value (post 30 versus pre) 0.832 0.601 0.115
High sensitivity troponin (ng/mL)
 Post 0.00 (0.00, 0.00) 0.00 (0.00, 1.18) 0.00 (0.00, 5.26)
 Post 30 min 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.00 (− 18.61, 0.00)
 p value (post versus pre) 0.269 0.058 0.788
 p value (post 30 versus pre) 0.576 0.779 0.296
Creatine kinase-MBm (ng/mL)
 Post 1.68 (− 4.77, 8.70) − 0.51 (− 5.86, 8.29) 3.30 (− 7.18, 13.06)
 Post 30 min − 0.84 (− 5.86, 8.61) − 2.51 (− 7.77, 7.79) 0.51 (− 9.54, 25.86)
 p value (post versus pre) 0.453 0.632 0.526
 p value (post 30 versus pre) 0.128 0.351 0.236
NT-proBNP (ng/L)
 Post 12.00 (9.44, 17.70) 17.57 (9.38, 28.35) 9.79 (0.08, 14.14)
 Post 30 min 13.93 (7.61, 29.66) 26.42 (11.78, 41.90) 8.19 (− 5.50, 18.01)
p value (post versus pre) < 0.001 < 0.001 0.077
p value (post 30 versus pre) < 0.001 < 0.001 0.073
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in NT-proBNP was observed after 10-km recreational run-
ning exercise session [46]. N-terminal pro-B-type natriu-
retic peptides, which are the more stable by-products of 
circulating B-type natriuretic peptides, are known to play a 
role in the regulation of blood pressure and sodium balance 
[47]. Above the reference range, increased concentrations 
of NT-proBNP have been recommended for the diagnosis 
and treatment guidance of heart failure [48, 49]. Recent evi-
dence suggests that information on NT-proBNP is predictive 
of first-onset heart failure, CHD, and stroke [33]. Another 
finding in our study was a slight increase in levels of hs-
troponin I in males immediately after sauna, but the differ-
ence was marginally significant. Troponin is released from 
the cytosolic pool of the myocytes and it may be released 
during prolonged ischemia with degradation of actin and 
myosin filaments and it has been even used as a marker of 
minor cardiac muscle injury [50]. Compared with the older 
troponin assays, hs-troponin I assays improve the speed 
of diagnosis and are well-suited for detecting sub-clinical 
cardiac structural abnormalities [50, 51]. High-sensitivity 
cardiac troponins have also been suggested to be prognostic 
biomarkers for cardiovascular events in normal- and high-
risk general populations [52]. The minor changes in levels 
of these markers could be due to the short-term nature of 
the sauna exposure (only 30 min). Previous studies of other 
passive heat therapies with longer exposure time have dem-
onstrated marked changes in levels of some of these circulat-
ing biomarkers [43, 44]. Long-term intervention studies are 
indeed warranted to study the effects of sauna bathing on 
these cardiac-specific biomarkers.
To our knowledge, we have conducted the first study 
to evaluate the acute effects of 30-min sauna exposure on 
emerging biomarkers for cardiovascular function, based on 
traditional hot and dry Finnish sauna bathing which is a dif-
ferent exposure compared to other passive heat therapies 
such as warm water immersion, Waon therapy, and infrared 
heat, which are characterized by lower temperatures. Given 
the experimental setting of the current study, the number of 
study subjects recruited was adequate to assess any meaning-
ful clinical changes in indices evaluated. The intervention 
simulated a typical dry and hot Finnish sauna session which 
lasted for 30 min and no adverse events occurred duration 
the entire duration of the study. These observations suggest 
that 30 min of sauna bathing can be considered a safe activ-
ity for the cardiovascular system, findings which are consist-
ent with reports that regular sauna bathing can be safely rec-
ommended for majority of healthy people and patients with 
stable heart disease [32]. A number of limitations deserve 
consideration. A major limitation was that study participants 
were not sauna-naive users or did not include non-sauna 
users, which could have caused biases as the intervention is 
not novel to study participants. This situation could not be 
avoided, because the majority of the Finnish population are 
sauna users, given that sauna bathing is embedded in the 
tradition. The intervention was short-term and we employed 
a before- and after-design without the use of a control; how-
ever, this study was designed to be a pilot study and was 
exploratory in nature given the novel nature of the topic. We 
had measurements of NT-proBNP in only a small number of 
participants, which was due to the costs associated with such 
measurements. Follow-up period of recovery was limited 
to a 30-min period. Due to the novel study protocol which 
focused on acute changes in inflammatory, muscle and car-
diac biomarkers, we did not assess prolonged or long-lasting 
changes hours or days after sauna exposure.
Conclusions
Our experimental study suggests that levels of NT-proBNP 
and creatine kinase increase after short-term sauna expo-
sure. These changes are more evident in males. Long-term 
interventional studies are warranted to evaluate if these bio-
markers are involved in pathways underlying the protective 
associations of sauna bathing with adverse cardiovascular 
outcomes.
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